Warren Buffett keeps selling billions worth of stock in this frothy market — here are 3 new places where he’s finding value
Down 30% in 6 Months: Is Tilray Still a Buy?
The Canadian cannabis company Tilray (NASDAQ: TLRY) hasn’t been the best performer over the last six months, with its shares falling by more than 31% while the larger market rose by 14%. Is Tilray on track to be a strong performer in 2022, or is its tenuous positioning relative to the rapidly opening U.S. cannabis market going to be a problem? Right now, Tilray holds the largest share of the recreational and medicinal cannabis markets in Canada.